SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-320404
Filing Date
2021-11-04
Accepted
2021-11-04 17:27:04
Documents
13
Period of Report
2021-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d254853d8k.htm   iXBRL 8-K 28186
2 EX-10.1 d254853dex101.htm EX-10.1 191845
  Complete submission text file 0001193125-21-320404.txt   402517

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cdak-20211104.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdak-20211104_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdak-20211104_pre.xml EX-101.PRE 11861
6 EXTRACTED XBRL INSTANCE DOCUMENT d254853d8k_htm.xml XML 3472
Mailing Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGEPARK DRIVE SUITE 500 CAMBRIDGE MA 02140 617-949-4100
Codiak BioSciences, Inc. (Filer) CIK: 0001659352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39615 | Film No.: 211381258
SIC: 2836 Biological Products, (No Diagnostic Substances)